Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acanthopanax senticosus sugar-free granules
- Development stage
- Preclinical
- Lead developer
- Wusuli River Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Acanthopanax senticosus sugar-free granules is an improved Traditional Chinese Medicine (TCM) formulation developed by Wusuli River Pharmaceutical. Derived from the root and rhizome of *Acanthopanax senticosus* (also known as Siberian Ginseng or Ciwujia), this product is classified as an "improved new drug" (改良型新药) under the Chinese regulatory framework. The formulation is specifically designed to be sugar-free, making it a suitable therapeutic option for patients with diabetes or those requiring sugar-restricted diets. *Acanthopanax senticosus* is traditionally utilized for its adaptogenic properties, which include enhancing immune function, reducing fatigue, and supporting cardiovascular and cerebrovascular health. The drug is currently undergoing registration approval and formulation improvement research in China.
- Other names
- 刺五加无糖颗粒Acanthopanax sugar-free granule formulationCiwujia sugar-free granules
Beyond the preview
Go deeper on Acanthopanax senticosus sugar-free granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acanthopanax senticosus sugar-free granules.